Anticancer agent 259
Anticanceragent 259 (Compound 3g) is a telmisartan-derived small molecule that acts as a STAT5 pathway inhibitor, resensitizing imatinib-resistant cells with an SC50 of 1.5 μM. It is a valuable research tool for studying STAT5-dependent signaling and overcoming drug resistance in hematological cancers, as demonstrated in in vitro studies.
Product Specifications
Field of Research
Signal Transduction, Stem Cell & Developmental Biology
Molecular Formula
C30H26N2O2
Molecular Weight
446.54
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6334686-01 0.2 mL
PLCB2, NT (PLCB2, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2, Phosphoinositide phospholipase C-beta-2, Phospholipase C-beta-2) (APC)
Sign In for Pricing
View Details 
MBS6334686-02 5x 0.2 mL
PLCB2, NT (PLCB2, 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2, Phosphoinositide phospholipase C-beta-2, Phospholipase C-beta-2) (APC)
Sign In for Pricing
View Details GTR15181986 1 Vial
Lentiviral mouse Plch1 shRNA (UAS) - Lentiviral mouse Plch1 shRNA (UAS) (100)
Sign In for Pricing
View Details